Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Recruiting · NCT06155383 · Registry updated 2023-12-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma. | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, gastroesophageal junction adenocarcinoma, neoplasm, stomach disorder | Recruiting | Phase 2 | 2023-12-14 | NCT06155383 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RemeGen Co., Ltd. | 36 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 1 |
| Fujian Cancer Hospital | Fuzhou | China | 55 |
| Gansu Wuwei Tumour Hospital | Wuwei | China | 2 |
| Guangdong Provincial People's Hospital | Guangzhou | China | 59 |
| Harbin Medical University Cancer Hospital | Harbin | China | 51 |
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Nanfang Hospital | Guangzhou | China | 16 |
| Shandong Cancer Hospital & Institute | Jinan | China | 1 |
| Sichuan Cancer Hospital & Institute | Chengdu | China | 3 |
| The First Affiliated Hospital Of Xiamen University | Xiamen | China | 50 |
| Yunnan Cancer Hospital | Kunming | China | 1 |